Abstract

Programmed death ligand 1 (PD-L1) expression on the surface of cancer cells affects the efficacy of anti-PD-1/PD-L1 immune checkpoint therapy. However, the mechanism underlying PD-L1 expression in cancer cells is not fully understood, particularly after ionizing radiation (IR). Here, we examined the impact of high linear energy transfer (LET) carbon-ion irradiation on the expression of PD-L1 in human osteosarcoma U2OS cells. We found that the upregulation of PD-L1 expression after high LET carbon-ion irradiation was greater than that induced by X-rays at the same physical and relative biological effectiveness (RBE) dose, and that the upregulation of PD-L1 induced by high LET carbon-ion irradiation was predominantly dependent on ataxia telangiectasia and Rad3-related (ATR) kinase activity. Moreover, we showed that the downstream signaling, e.g. STAT1 phosphorylation and IRF1 expression, was upregulated to a greater extent after high LET carbon-ion irradiation than X-rays, and that IRF1 upregulation was also ATR dependent. Finally, to visualize PD-L1 molecules on the cell surface in 3D, we applied immunofluorescence-based super-resolution imaging. The three-dimensional structured illumination microscopy (3D-SIM) analyses revealed substantial increases in the number of presented PD-L1 molecules on the cell surface after high LET carbon-ion irradiation compared with X-ray irradiation.

Details

Title
High linear energy transfer carbon-ion irradiation upregulates PD-L1 expression more significantly than X-rays in human osteosarcoma U2OS cells
Author
Tiara Bunga Mayang Permata 1 ; Sato, Hiro 1 ; Gu, Wenchao 2 ; Kakoti, Sangeeta 1 ; Uchihara, Yuki 2 ; Yoshimatsu, Yukihiko 2 ; Sato, Itaru 2 ; Kato, Reona 3 ; Yamauchi, Motohiro 4 ; Suzuki, Keiji 5 ; Oike, Takahiro 1 ; Tsushima, Yoshito 2 ; Gondhowiardjo, Soehartati 6 ; Ohno, Tatsuya 1 ; Yasuhara, Takaaki 3 ; Shibata, Atsushi 2 

 Department of Radiation Oncology , Gunma University, Maebashi, Gunma, 371-8511, Japan 
 Gunma University Initiative for Advanced Research (GIAR) , Gunma University, Maebashi, Gunma, 371-8511, Japan 
 Laboratory of Molecular Radiology , Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8655, Japan 
 Department of Radiation Biology and Protection , Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, 852-8523, Japan 
 Department of Radiation Medical Science , Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, 852-8523, Japan 
 Department of Radiation Oncology , Faculty of Medicine Universitas Indonesia – Dr. Cipto Mangunkusumo Hospital, Jakarta, 10430, Indonesia 
Pages
773-781
Publication year
2021
Publication date
Sep 2021
Publisher
Oxford University Press
ISSN
04493060
e-ISSN
13499157
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3171179842
Copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.